Reviewing Pheton (NASDAQ:PTHL) & OptimizeRx (NASDAQ:OPRX)

OptimizeRx (NASDAQ:OPRX) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Valuation and Earnings

This table compares OptimizeRx and Pheton”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43 million	1.35	$5.13 million	$0.23	34.22
Pheton	$305,215.00	6.90	-$660,000.00	N/A	N/A

OptimizeRx has higher revenue and earnings than Pheton.

Volatility and Risk

OptimizeRx has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Comparatively, Pheton has a beta of 5.4, indicating that its share price is 440% more volatile than the S&P 500.

Profitability

This table compares OptimizeRx and Pheton’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Pheton	N/A	N/A	N/A

Institutional and Insider Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for OptimizeRx and Pheton, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Pheton	1	0	0	0	1.00

OptimizeRx currently has a consensus target price of $11.43, indicating a potential upside of 45.22%. Given OptimizeRx’s stronger consensus rating and higher possible upside, equities analysts plainly believe OptimizeRx is more favorable than Pheton.

Summary

OptimizeRx beats Pheton on 10 of the 12 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.